5842 Integral
- 3765
- +5+0.13%
Integral News
Integral Ad Science Announces Partnership With Kwai
IAS Announces Exclusive First-to-Market Partnership With Kwai for Business to Provide Content-Level Brand Safety and Suitability Measurement for Advertisers
Morgan Stanley Alters Stake in Integral Diagnostics
Integral Diagnostics Ltd. Sees Shift in Substantial Holdings
IAS Introduces New Quality Attention Optimization and Social Attention Measurement
The Tokyo Stock Exchange Growth Index continues to decline, with lackluster price movements ahead of the Japan and US central bank meetings.
Tokyo Stock Exchange Growth Market Index 814.89 -2.43 / Volume 0.2 billion 14.75 million shares / Trading value 145.5 billion yen Tokyo Stock Exchange Growth Market 250 Index 635.44 -2.83 / Volume 0.1 billion 5.09 million shares / Trading value 97.2 billion yen Today's growth market saw a continued decline in both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, with 187 rising stocks, 363 declining stocks, and 45 unchanged. Today's growth market showed a soft trend. On the previous day, October 16 in the USA.
Overview of the TSE Growth Market 250 Index Futures: Decline observed due to expectations of a halt in US interest rate cuts.
On December 17, the Tokyo Stock Exchange Growth Market 250 Index Futures fell 5 points to 622 points compared to the previous trading day. The high was 628 points, the low was 620 points, and the intraday trading volume was 2,119 contracts. The Dow Inc average on the US market on the previous day, December 16, declined for the eighth consecutive day. Following the opening, there was a slight increase due to expectations of additional interest rate cuts at the Federal Open Market Committee (FOMC) meeting scheduled for midweek. The December services PMI indicated a high level not seen in about three years, showing an acceleration in the pace of expansion, which boosted the increase but the decline continues.
Integral Diagnostics' Merger Could Deliver Revenue Synergies -- Market Talk
Integral Diagnostics Target Price Raised 21% to A$3.50/Share by Macquarie>IDX.AU
BlackBerry Shares Rise 18% on Sale of Cybersecurity Unit to Arctic Wolf
Integral Ad Science Received an Accredited ISO/IEC 42001 Certification
Perpetual Limited Gains Stake in Integral Diagnostics
Integral Corporation Completes Tender Offer for Mutoh Holdings Shares
Jarden Sticks to Its Buy Rating for Integral Diagnostics Ltd. (IDX)
AtNorth Strengthens Team With Two Key Director Appointments
Returns Are Gaining Momentum At Integral Ad Science Holding (NASDAQ:IAS)
Jarden Adjusts Integral Diagnostics' Price Target to AU$3.68 From AU$3.72, Keeps at Buy
Integral Diagnostics Target Price Cut 1.1% to A$3.68/Share by Jarden>IDX.AU
Integral Diagnostics Plans Major Securities Issue
ACCC Conditionally Clears Integral Diagnostics' Proposed Acquisition of Capitol Health
No Data